11.06.2012 | The Geneva Forum for Sustainable Investment 2012 edition was a success

pdfThe Geneva Forum for Sustainable Investment 2012 edition was a success

Symbiotics was a lead sponsor, with Banque Sarasin, of the 2012 edition of the Geneva Forum Sustainable Investment held on June 8th.  Over 200 participants joined the conference organized by Sustainable Finance Geneva and European Investor Relations. They included many private bankers and institutional investors, but also private and corporate investors.

Paul Polman, CEO of Unilever, gave the keynote speech on sustainable growth and long term business models. Roland Dominicé, CEO of Symbiotics presented the company's new fund of fund, "Symbiotics Emerging Sustainable Funds". Other topics, all analyzed and discussed through the lense of sustainability criteria, included Swiss real estate, the Swiss SME market, global finance, bond fund management, resource scarcity, agricultural finance and impact measurement. The day ended with a roundtable entitled: "From microfinance to impact investing" moderated by Fabio Sofia, head of Investor Relations at Symbiotics.

For more information:

 

Claire Dorey

Communication Officer

+ 41 (0)22 338 15 40

claire.dorey@symbioticsgroup.com

 

Legal Disclaimer: The collective investment schemes (the “Investment Products”) referred to on the following pages have not been approved for public distribution in or from Switzerland by the Swiss Financial Market Supervisory Authority (FINMA) pursuant to the Swiss Collective Investment Schemes Act of 23 June 2006 (the "CISA") and its implementing regulations. Accordingly, units of such Investment Products and information, documents or material pertaining to these Investment Products on the following pages may only be distributed in or from Switzerland to qualified investors (as such term is defined in the CISA and its implementing regulations). The information, documents and material pertaining to these Investment Products on the following pages are strictly confidential and do not constitute an offer to any other person or entity than Swiss qualified investors and may only be used by those qualified investors who have accessed them. They may not be copied, used by, distributed or made available to any other person.

Similarly the information on the following pages is only intended to be viewed by persons who fall outside the scope of any law that seeks to regulate financial promotions in the country of your residence or in the country in which the content of this website is being viewed.

If you are uncertain about your position under the laws of the country in which the content of this website is being viewed then you should seek clarification by obtaining legal advice from a lawyer practicing in the country of your residence or in the country in which the content of this website is being viewed before accessing this website.

The information, documents and material contained in the following pages are not warranted to be accurate, complete, or timely. More specifically, Symbiotics SA may not be held responsible for and does not take any position with respect to the accuracy and completeness of information in the following pages.

Agree    Disagree